Get started
Author

Thomas Suedhoff

Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
2014 · G. Folprecht, T. Gruenberger, et al. · Annals of Oncology · 270
PDF
Detection ofAspergillusSpecies in Blood and Bronchoalveolar Lavage Samples from Immunocompromised Patients by Means of 2‐Step Polymerase Chain Reaction: Clinical Results
2001 · Dieter Buchheidt, Corinna Baust, et al. · Clinical Infectious Diseases · 148
Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies
2012 · M. Reinwald, M. Hummel, et al. · Journal of Antimicrobial Chemotherapy · 94
Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
2011 · B. Walter, I. Schrettenbrunner, et al. · Medical Oncology · 30
C-reactive Protein in Patients with Metastatic Clear Cell Renal Carcinoma: An Important Biomarker for Tumor-associated Inflammation
2006 · Albrecht Reichle, Jochen Grassinger, et al. · Biomarker Insights · 23
Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
2014 · M. Vogelhuber, S. Feyerabend, et al. · Cancer Microenvironment · 15
PDF
Survival with cetuximab/FOLFOX or cetuximab/FOLFIRI of patients with nonresectable colorectal liver metastases in the CELIM study.
2012 · Gunnar Folprecht, Thomas Gruenberger, et al. · Journal of Clinical Oncology · 13
A phase II study of imatinib with pioglitazone, etoricoxib, dexamethasone, and low-dose treosulfan: Combined anti-inflammatory, immunomodulatory, and angiostatic treatment in patients (pts) with castration-refractory prostate cancer (CRPC).
2011 · A. Reichle, M. Vogelhuber, et al. · Journal of Clinical Oncology · 10
Dyshematopoiesis in De Novo Acute Myeloid Leukemia: Cell Biological Features and Prognostic Significance
1998 · G. Meckenstock, C. Aula B. Hildebrandt, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 9
6009 POSTER DISCUSSION Progression Free and Overall Survival After Neoadjuvant Treatment of Colorectal Liver Metastases With Cetuximab Plus FOLFOX or FOLFIRI – Results of the CELIM Study
2011 · G. Folprecht, T. Gruenberger, et al. · European Journal of Cancer · 7
Cetuximab and chemotherapy in the treatment of patients with initially “nonresectable” colorectal (CRC) liver metastases: Long-term follow-up of the CELIM trial.
2013 · Gunnar Folprecht, Thomas Gruenberger, et al. · Journal of Clinical Oncology · 6
Ceftriaxone in the Treatment of Solid Tumour Patients with Febrile Neutropenia
1998 · M. Karthaus, H.H. Wolf, et al. · Oncology Research and Treatment · 5
C-Reactive Protein As a Secretome-Derived Biomarker for Predicting Response to Biomodulatory Therapy in Metastatic Renal Clear Cell Carcinoma
2010 · Bernhard Walter, Irmela Schrettenbrunner, et al. · Springer eBooks · 3
Effect of anti-inflammatory therapy in patients with metastatic renal cell carcinoma on clinical response
2006 · A. Reichle, J. Grassinger, et al. · Journal of Clinical Oncology · 1
Prognostic value of pre-infection routine laboratory parameters for COVID-19 mortality in tumor patients: Results of the ADHOK Coronavirus Tumor Registry.
2021 · Romina Roesch, Thomas Suedhoff, et al. · Journal of Clinical Oncology
Erratum to: Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
2015 · M. Vogelhuber, S. Feyerabend, et al. · Cancer Microenvironment
PDF
Redirecting and Modulating Rationalizations of Tumor-Immanent Normative Functions in Castration-Resistant Prostate Cancer
2013 · M. Vogelhuber, S. Feyerabend, et al. · Springer eBooks
Survival of patients with initially non-resectable colorectal liver metastases following systemic treatment with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM-study)
2013 · Folorecht, G., Gruenberger, Thomas, et al. · GRO
Progression Free and Overall Survival After Neoadjuvant Treatment of Colorectal Liver Metastases With Cetuximab Plus FOLFOX or FOLFIRI - Results of the CELIM Study
2011 · Folprecht, Gunnar, Gruenberger, Thomas, et al. · GRO
Arterial vasocontraction is a frequent finding following 5-fu based chemotherapy
2003 · Thomas Suedhoff, Markus Reiser, et al. · Gastroenterology
PDF
Book Reviews · Buchbesprechnungen
1998 · W. Willenbacher, A. Mumm, et al. · Oncology Research and Treatment
PDF
Works count: 21
Citation count: 634
H-index: 9
I10-index: 8
Year
Topic
Type